Interdisciplinary

Personalized Cancer Models Predict Individual Breast Cancer Risk More Accurately

How the science connects

Computational mode…Systems biology

AI Insight

Researchers developed a computational framework that combines individual gene expression data with dynamic modeling of cellular signaling pathways to predict breast cancer risk in 30 subjects. The model successfully stratified individuals into four risk groups with significantly different disease-free survival periods, with the highest-risk group showing a median disease-free period of 6.05 years. This high-risk phenotype was characterized by hyperactive MAPK signaling pathway activity, particularly elevated levels of phosphorylated ERK, phosphorylated RSK, and c-Fos.


This approach could improve upon traditional breast cancer risk assessment models by incorporating molecular-level information about cellular signaling dynamics, potentially enabling more personalized prevention strategies and earlier interventions for high-risk individuals.


Understand the Science

by Piyanut Ratphibun Yamashita, Anuwat Tangthanawatsakul, Teerasit Termsaithong, Yaowaluck Maprang Roshorm, Teeraphan Laomettachit

Breast cancer is the most common cancer in women and a leading cause of death. Traditional risk assessment models, such as the Gail model, lack molecular insight, limiting their usefulness for personalized prevention strategies. We developed a computational framework that integrates individual transcriptomic data with dynamic modeling of cell signaling to create personalized models for 30 subjects (including 15 who later developed breast cancer). Using features extracted from the dynamic simulation, we stratified individuals into four risk clusters with significantly different disease-free periods. The highest-risk group had a median disease-free period of 6.05 years, which is significantly shorter than that of the other clusters. This high-risk phenotype was characterized by hyperactive MAPK signaling (high phosphorylated ERK, phosphorylated RSK, and c-Fos). This approach demonstrates that interactions among pathway components provide additional information beyond static gene expression profiles in risk assessment and may serve as a promising tool for guiding personalized prevention strategies.

Source: Integrating dynamic modeling of signaling pathways with subject-specific transcriptomic data to assess breast cancer risk